Feeling the elephant of cardiovascular cell therapy

Circulation

Volumn 121, Issue 2, 2010, Pages 197-199

  Rehman, Jalees ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; EDITORIAL; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEART FUNCTION; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; COMMUNICATION; COOPERATIVE BEHAVIOR; HUMANS; REFERENCE STANDARDS; STEM CELL TRANSPLANTATION;

EID: 74949094846     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.912105     Document Type: Editorial

References (19)

1. Rumi. Tales from the Masnavi. Surrey: Curzon Press; 1993.
2. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature. 2008;453:322-329.
3. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008; 451:937-942.
4. Rubart M, Field LJ. Cardiac regeneration: repopulating the heart. Ann Rev Physiol. 2006;68:29-49.
5. Sieveking DP, Ng MK. Cell therapies for therapeutic angiogenesis: back to the bench. Vascular Med. 2009;14:153-166.
6. Kovacic JC, Moore J, Herbert A, Ma D, Boehm M, Graham RM. Endo-thelial progenitor cells, angioblasts, and angiogenesis: old terms reconsidered from a current perspective. Trends Cardiovasc Med. 2008;18: 45-51.
7. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb VascBiol. 2008; 28:1584-1595.
8. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103:1204-1219.
9. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989-997.
10. Zhao YD, Ohkawara H, Rehman J, Wary KK, Vogel SM, Minshall RD, Zhao YY, Malik AB. Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling. Circ Res. 2009;105:696-704.
11. Hristov M, Gumbel D, Luthgens E, Zernecke A, Weber C. Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury. Circulation. 2010;121:315-324.
12. George J, Afek A, Abashidze A, Shmilovich H, Deutsch V, Kopolovich J, Miller H, Keren G. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apoli-poprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2005;25: 2636-2641.
13. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: linking inflammation with athero-thrombosis. J Am Coll Cardiol. 2009;54:669-677.
14. Donners MM, Beckers L, Lievens D, Munnix I, Heemskerk J, Janssen BJ, Wijnands E, Cleutjens J, Zernecke A, Weber C, Ahonen CL, Benbow U, Newby AC, Noelle RJ, Daemen MJ, Lutgens E. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood. 2008;111:4596-4604.
15. Zhang Y, Ingram DA, Murphy MP, Saadatzadeh MR, Mead LE, Prater DN, Rehman J. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol. 2009;296:H1675-H1682.
16. Schonbeck U, Varo N, Libby P, Buring J, Ridker PM. Soluble CD40L and cardiovascular risk in women. Circulation. 2001;104:2266-2268.
17. Zhang Y, Herbert BS, Rajashekhar G, Ingram DA, Yoder MC, Clauss M, Rehman J. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway. Faseb J. 2009;23:1358-1365.
18. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circulation Res. 2008;102:1319-1330.
19. Penn MS, Mangi AA. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circulation Res. 2008;102:1471-1482.